Phasebio Pharmaceuticals Inc (PHAS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | PHAS | BMY | AMGN | GILD | MRNA |
| Company | Phasebio Pharmaceuticals Inc | Bristol-Myers Squibb Company | Amgen Inc | Gilead Sciences Inc | Moderna Inc |
| Price Information | |||||
| Exchange | NASDAQ | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.0800 | 49.00 | 270.63 | 66.58 | 111.05 |
| High | 0.0920 | 49.05 | 274.86 | 67.19 | 111.29 |
| Low | 0.0665 | 48.55 | 269.65 | 66.37 | 106.64 |
| Last | 0.0701 | 48.82 | 273.58 | 66.88 | 108.98 |
| Change | -0.0249 | -0.17 | +0.04 | -0.15 | +1.09 |
| % Change | -26.21% | -0.35% | +0.01% | -0.22% | +1.01% |
| Volume | 9,647,400 | 12,356,134 | 1,245,483 | 5,007,337 | 2,654,798 |
| 20-Day Average Volume | 3,930,150 | 11,041,454 | 2,108,722 | 6,289,264 | 3,184,581 |
| Previous Close | 0.0950 | 48.99 | 273.54 | 67.03 | 107.89 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.1610 | 50.37 | 271.58 | 69.06 | 105.21 |
| 20-Day Raw Stochastic | 2.27% | 18.22% | 46.49% | 11.61% | 61.65% |
| 20-Day Relative Strength | 20.88% | 41.17% | 48.80% | 32.23% | 56.26% |
| Weighted Alpha | -91.26 | -26.01 | +11.51 | -21.19 | -8.63 |
| Today's Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 88% Buy |
| Previous Opinion | 100% Sell | 88% Sell | 40% Sell | 100% Sell | 88% Buy |
| Last Month's Opinion | 72% Sell | 8% Sell | 24% Buy | 88% Sell | 72% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -42.40% since 10/26/22 | +2.14% since 04/17/24 | +3.63% since 04/17/24 | -0.16% since 04/17/24 | +5.03% since 04/17/24 |
| Low | 0.0665 on 11/02/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 99.30 on 04/22/24 |
| High | 0.1440 on 10/27/22 | 49.56 on 04/22/24 | 274.86 on 04/24/24 | 67.68 on 04/23/24 | 111.19 on 04/24/24 |
| 1-Month | |||||
| %Chg | -60.17% since 09/30/22 | -5.90% since 03/22/24 | -0.91% since 03/22/24 | -7.97% since 03/22/24 | +3.05% since 03/22/24 |
| Low | 0.0665 on 11/02/22 | 47.62 on 04/18/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 97.00 on 04/03/24 |
| High | 0.2250 on 10/14/22 | 54.47 on 03/28/24 | 288.57 on 03/28/24 | 73.87 on 03/28/24 | 115.89 on 04/09/24 |
| 3-Month | |||||
| %Chg | -93.85% since 08/02/22 | -2.74% since 01/24/24 | -10.43% since 01/24/24 | -15.98% since 01/24/24 | +7.45% since 01/24/24 |
| Low | 0.0665 on 11/02/22 | 47.58 on 02/06/24 | 260.68 on 04/19/24 | 65.90 on 04/18/24 | 84.06 on 02/13/24 |
| High | 1.3800 on 08/09/22 | 55.03 on 03/13/24 | 329.72 on 02/05/24 | 81.06 on 01/25/24 | 115.89 on 04/09/24 |
| 6-Month | |||||
| %Chg | -94.35% since 05/02/22 | -12.93% since 10/24/23 | -0.90% since 10/24/23 | -14.49% since 10/24/23 | +36.21% since 10/24/23 |
| Low | 0.0665 on 11/02/22 | 47.58 on 02/06/24 | 249.70 on 10/31/23 | 65.90 on 04/18/24 | 62.55 on 11/02/23 |
| High | 1.3800 on 08/09/22 | 56.77 on 10/25/23 | 329.72 on 02/05/24 | 87.86 on 01/19/24 | 115.97 on 01/08/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 3,495 | 99,290,928 | 146,720,288 | 83,457,512 | 41,308,924 |
| Shares Outstanding, K | 49,858 | 2,026,759 | 536,376 | 1,245,077 | 382,880 |
| Annual Sales | 10,830,000 | 45,006,000,000 | 28,190,000,000 | 27,116,000,000 | 6,848,000,000 |
| Annual Net Income | -131,070,000 | 8,025,000,000 | 6,717,000,000 | 5,665,000,000 | -4,714,000,000 |
| Last Quarter Sales | 210,000 | 11,477,000,000 | 8,196,000,000 | 7,114,000,000 | 2,811,000,000 |
| Last Quarter Net Income | -16,670,000 | 1,762,000,000 | 767,000,000 | 1,429,000,000 | 217,000,000 |
| 60-Month Beta | 2.57 | 0.39 | 0.58 | 0.19 | 1.62 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.34 on 08/12/22 | 1.70 on 02/02/24 | 4.71 on 02/06/24 | 1.72 on 02/06/24 | 0.55 on 02/22/24 |
| Latest Earnings Date | 11/09/22 | 04/25/24 | 05/02/24 | 04/25/24 | 05/02/24 |
| Most Recent Dividend | N/A | 0.600 on 04/04/24 | 2.250 on 02/15/24 | 0.770 on 03/14/24 | N/A |
| Next Ex-Dividends Date | N/A | 04/04/24 | 05/16/24 | 03/14/24 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 6.55 | 14.58 | 9.96 | 0.00 |